Why the Vaccine Selection Has To Be A Careful Process

Everyone is ready for a vaccine but there is just too much misinformation creating unrest amongst the world population


Photo courtesy: Euronews

Not all vaccine candidates will suit every country in the same way. There are a whole lot of reasons behind why a certain country might not benefit from the research of Pfizer or Moderna after all. 

The race for the vaccine was one thing; corruption and misinformation is already doing arounds across the length and breath of the  globe. 

Pfizer and BioNtech are confident of the efficacy of the Covid-19 vaccine that they have come up with.

They are now looking for authorisation in Europe for the use of emergency use of their Covid-19 vaccine candidate.

Moderna is also confident about the efficacy of their vaccine candidate. This is coming at a time when the news was doing rounds that former Vice President of Pfizer said 'the virus is over and herd immunity has done its wonder. We don't need a vaccine anymore'.

According to the former Vice President and Chief Scientist of the company Dr. Michael Yeadon there is no need for any vaccines. " We can just follow hygiene protocols and the NHS can handle the rest. In our minds, we need to bring the COVID-19 pandemic to an end."

Ironically, the UK government recently gave a green signal to the Pfizer vaccine usage from next week. In India, the AIIMS Director is vouching for their own and dont think Pfizer is needed as the Indian one is more sturdy to withhold Indian climatic conditions.  

New of black marketing are common across China, India and US. The prices are going to be high. Then there is the issue of countries buying in bulk irrespective of the Covax norms laid out by UN.

The European Union is still tight on its norms and is hoping it can bring forth fair and just dissemination of doses. The latest announcement means Pfizer's vaccine could become available in the European Union for vulnerable groups before the end of the year if the EMA "concludes that the benefits of the vaccine candidate outweigh its risks.

Meanwhile UAE has developed its own vaccine and is helping free dosages for its citizens. Based on stem-cell technology, they are one nation that is away from all this mess and takes its disaster management quiet seriously. 

There is some truth is what Indian counterparts are claiming over temperature restrictions of storing the Pfizer doses. The vaccine, like the one developed by Moderna, is based on new technology that contains mRNA or genetic instructions that help the body to recognise the coronavirus' spike protein, which is used to enter the body's cells.

The Pfizer/BioNTech vaccine, will need to be stored at ultracold temperatures (-70 degrees Celsius), the infrastructure for which doesn't exist in many places.

This means that many countries are unlikely to have the capacity to distribute the vaccine. 

Comments

Popular posts from this blog

Why Is Truss Government Looking At Relaxing Immigration Rules?

Iranian President Refuses Interview To CNN Reporter In The US